Login | Register

Levemir Approved For Diabetes During Pregnancy, USA

The U.S. Food and Drug Administration (FDA) has just approved LevemirĀ®, an insulin detemir [rDNA origin] injection, as the first and only basal insulin analog for Pregnancy Category B classification, which indicates that LevemirĀ® does not pose a higher risk of harm for the unborn when used in pregnant women with diabetes. The drug is manufactured by Novo Nordisk...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *